Dispense Times Magazine – December 2024 Issue

The FDA has closed the shortage loophole that fueled the compounded GLP-1 boom. With semaglutide and tirzepatide off the shortage list, compounding pharmacies and telehealth platforms face a new era of enforcement, audits, and market consolidation.

Marketing is essential for patient growth. By leveraging digital...

PBMs play a significant role in the pharmacy ecosystem....

This article highlights key insights from industry leaders at the 2026 Asembia meeting, emphasizing the rapid transformation of specialty pharmacy. It explores how advancements in AI, interoperability, and digital navigation are reshaping patient care and operational strategies. Independent pharmacy owners will gain valuable perspectives on adapting to these changes to maintain high-touch care while leveraging high-tech capabilities.

This article challenges independent pharmacy owners and staff to rethink continuing education (CE) from a simple compliance checkbox to a strategic investment in professional capability. It highlights how targeted CE can empower both pharmacists and technicians to confidently expand clinical services and improve patient care. Ultimately, the piece argues that relevant, team-based education is essential for pharmacies aiming to stay competitive and meet evolving healthcare demands.